COMMUNIQUÉS West-GlobeNewswire

Spark Therapeutics to Participate in Multiple Conferences in January

02/01/2018 - 13:30

PHILADELPHIA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that Jeffrey D. [...]

Aptose Biosciences to Present at Biotech Showcase™ 2018 Conference

02/01/2018 - 13:30

SAN DIEGO and TORONTO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms [...]

Agios to Present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018

02/01/2018 - 13:30

CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the company is [...]

BioCorRx CEO, Brady Granier, Appears on Fox & Friends to Discuss the Opioid Epidemic

02/01/2018 - 13:30

ANAHEIM, CA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady [...]

G1 Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference

02/01/2018 - 13:00

RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will [...]

Apellis Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference

02/01/2018 - 13:00

CRESTWOOD, Ky. and CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]

Melinta Therapeutics Appoints Lisa DeFrancesco as Senior Vice President of Investor Relations

02/01/2018 - 13:00

NEW HAVEN, Conn., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing, and commercializing novel antibiotics to treat serious bacterial [...]

NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical Development

02/01/2018 - 13:00

Series A financing co-led by ArrowMark Partners and Barer & Son Capital Financing supports initiation of Phase I/II trial of AIM TM ACT in relapsed/refractory Hematologic Malignancies in 2018 GAITHERSBURG, Md., Jan [...]

Genmab to Present at the 36th Annual J.P. Morgan Healthcare Conference

02/01/2018 - 15:16

Media Release Copenhagen, Denmark; January 2, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 36 th Annual J.P. Morgan Healthcare [...]

Coherus BioSciences Management to Present at The 36th Annual J.P. Morgan Healthcare Conference

02/01/2018 - 15:00

REDWOOD CITY, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that senior management will present at the 36 th annual J.P. Morgan healthcare conference on Monday, [...]

Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

02/01/2018 - 15:00

SAN DIEGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced that Scott Struthers, Ph.D [...]

Predictive Technology Group Appoints Dr. Michael Dey To Board Of Directors

02/01/2018 - 15:00

SALT LAKE CITY, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED), announces the appointment of Michael Dey, Ph.D. to the Board of Directors of Predictive Technology Group, Inc. Dr. Dey [...]

Progenics Pharmaceuticals Completes Enrollment in Phase 3 Study of PSMA-Targeted Imaging Agent 1404

02/01/2018 - 14:30

NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, today [...]

Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency

02/01/2018 - 14:30

SEATTLE, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ: CASC ), a clinical-stage biopharmaceutical company, today announced that it received a product-specific pediatric waiver from the European [...]

Sarepta Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

02/01/2018 - 14:30

CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]

BriaCell To Attend Biotech Showcase™ 2018

02/01/2018 - 14:30

BERKELEY, Calif. and VANCOUVER, British Columbia, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]

Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications

02/01/2018 - 14:05

WALTHAM, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS ) announced today that Elhan Webb has joined the Company as Head of Investor Relations and External [...]

Peregrine Pharmaceuticals to Present at Biotech Showcase 2018

02/01/2018 - 14:05

TUSTIN, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ), a company committed to improving patient lives by manufacturing and delivering high quality biologics, [...]

Selecta Biosciences Announces FDA Acceptance of Investigational New Drug Application for LMB-100 and SVP-Rapamycin Combination Therapy

02/01/2018 - 14:05

WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding [...]